Experienced in Tissue Biopsy

Dr. Marta Penas-Prado

Neurology
1515 Holcombe Blvd, 
Houston, TX 
Experienced in Tissue Biopsy
1515 Holcombe Blvd, 
Houston, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Marta Penas-Prado is a Neurologist in Houston, Texas. Dr. Penas-Prado is rated as an Experienced provider by MediFind in Tissue Biopsy. Her top areas of expertise are Astrocytoma, Glioblastoma, Brain Tumor, Glioma, and Tissue Biopsy.

Her clinical research consists of co-authoring 96 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Tissue Biopsy.

Specialties
Neurology
Licenses
Psychiatry & Neurology in TX
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1515 Holcombe Blvd, Houston, TX 77030

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
Phase 2 Study of VAL-083 Treatment for MGMT Unmethylated Bevacizumab-naïve Glioblastoma in the Adjuvant or Recurrent Setting
Enrollment Status: Completed
Publish Date: August 29, 2025
Intervention Type: Drug
Study Drugs: VAL-083, Dianhydrogalactitol
Study Phase: Phase 2
Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients With Recurrent Select Rare CNS Cancers
Phase II Trial of the Immune Checkpoint Inhibitor Nivolumab in Patients With Recurrent Select Rare CNS Cancers
Enrollment Status: Completed
Publish Date: June 29, 2025
Intervention Type: Drug
Study Drug: Nivolumab
Study Phase: Phase 2
A Phase I Lead-In to a 2x2x2 Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme
A Phase I Lead-In to a 2x2x2 Factorial Trial of Temozolomide, Memantine, Mefloquine, and Metformin as Post-Radiation Adjuvant Therapy of Glioblastoma Multiforme
Enrollment Status: Terminated
Publish Date: May 07, 2025
Intervention Type: Drug
Study Drugs: Mefloquine, Memantine Hydrochloride, Metformin Hydrochloride, Temozolomide
Study Phase: Phase 1
A Phase I/II Clinical Trial of Autologous CMV-Specific Cytotoxic T Cells for GBM Patients
A Phase I/II Clinical Trial of Autologous CMV-Specific Cytotoxic T Cells for GBM Patients
Enrollment Status: Completed
Publish Date: June 18, 2023
Intervention Type: Other, Drug, Biological, Procedure
Study Drugs: Autologous Cytomegalovirus-Specific Cytotoxic T Lymphocytes, Temozolomide
Study Phase: Phase 1/Phase 2
Phase II Study of Single-agent Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Phase II Study of Single-agent Crenolanib in Recurrent/Refractory Glioblastoma With PDGFRA Gene Amplification
Enrollment Status: Completed
Publish Date: July 20, 2020
Intervention Type: Drug
Study Phase: Phase 2
Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas
Randomized, Double-Blind, Placebo-Controlled Trial of Lacosamide for Seizure Prophylaxis in Patients With High-Grade Gliomas
Enrollment Status: Terminated
Publish Date: December 19, 2018
Intervention Type: Other, Drug
Study Phase: Not Applicable
View 5 Less Clinical Trials

96 Total Publications

Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.
Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors.
Journal: Neuro-oncology advances
Published: July 30, 2025
Similar Doctors
Experienced in Tissue Biopsy
Dr. Shitiz K. Sriwastava
Neurology
Experienced in Tissue Biopsy
Dr. Shitiz K. Sriwastava
Neurology

Kelsey-Seybold Medical Group, PLLC

2727 W Holcombe Blvd, 
Houston, TX 
 (1.5 miles away)
713-442-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Shitiz Sriwastava is a Neurologist in Houston, Texas. Dr. Sriwastava is rated as a Distinguished provider by MediFind in Tissue Biopsy. His top areas of expertise are Progressive Multifocal Leukoencephalopathy, Encephalitis, CACH Syndrome, Multiple Sclerosis (MS), and Tissue Biopsy. Dr. Sriwastava is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Penas-Prado's expertise for a condition
ConditionClose
View All 8 Distinguished Conditions
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile